Venmax Drugs and Pharmaceuticals Ltd
Who owns it
Promoter holding fell 12.67pp across 8 quarters, from 23.13% to 10.46%.
None of the promoter’s holding is pledged, in any quarter of the series.
Loading the quarter figures…
Ownership shown is promoter, public and pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
No splits, bonuses, rights issues or other corporate actions are on record for Venmax Drugs and Pharmaceuticals Ltd since Aug 2024 — as far back as our records are certified complete.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as Venmax Drugs and Pharmaceuticals Ltd having paid none.
Fundamentals and valuation — we hold neither. The FII / DII / government split of public holding — not carried yet.
This page reports what Venmax Drugs and Pharmaceuticals Ltd disclosed to the exchange and how its shares have traded. It states no view on the stock and is not advice. Every figure is dated to the filing it came from; absence is stated, never shown as zero.